Pandemic Influenza Plasmid DNA Vaccines (Needle)

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

September 30, 2008

Conditions
Influenza
Interventions
BIOLOGICAL

VCL-IPT1

IM, 0.1 mg/mL, 2 injections, 0 and 21 days

BIOLOGICAL

VCL-IPT1

IM, 0.5 mg/mL, 2 injections, 0 and 21 days

BIOLOGICAL

VCL-IPT1

IM, 1 mg/mL, 2 injections, 0 and 21 days

BIOLOGICAL

VCL-IPM1

IM, 1 mg/mL, 2 injections, 0 and 21 days

BIOLOGICAL

PBS

IM, 1 mL, 2 injections, 0 and 21 days

Trial Locations (3)

21201

SNBL, Baltimore

92108

Accelovance, San Diego

11794-8153

SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Vical

INDUSTRY

NCT00709800 - Pandemic Influenza Plasmid DNA Vaccines (Needle) | Biotech Hunter | Biotech Hunter